3 Australian Growth Stocks With Revenue Growth Up To 38%

What happened: An article highlighted three Australian growth stocks, Mesoblast (ASX:MSB), Telix Pharmaceuticals (ASX:TLX) and Codan (ASX:CDA), framed around revenue growth and high insider ownership, with oil above US$110 a barrel cited as pushing energy costs into focus. Key numbers: Why it matters: The article says higher input prices tend to reward businesses that can grow fast enough to absorb them, and it points to analyst models building in optimism for Codan's defence communications growth and to Ryoncil uptake as positioning Mesoblast product revenue to scale from a low base. Coverage: 9 outlets in 24h

An article highlighted three Australian growth stocks, Mesoblast (ASX:MSB), Telix Pharmaceuticals (ASX:TLX) and Codan (ASX:CDA), framed around revenue growth and high insider ownership, with oil above US$110 a barrel cited as pushing energy costs into focus.

The article says higher input prices tend to reward businesses that can grow fast enough to absorb them, and it points to analyst models building in optimism for Codan's defence communications growth and to Ryoncil uptake as positioning Mesoblast product revenue to scale from a low base.